Hims & Hers Health (NYSE:HIMS) Shares Down 1.9% Following Insider Selling

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report)'s share price was down 1.9% during mid-day trading on Wednesday following insider selling activity. The stock traded as low as $51.41 and last traded at $52.33. Approximately 7,464,548 shares traded hands during mid-day trading, a decline of 62% from the average daily volume of 19,596,276 shares. The stock had previously closed at $53.36.

Specifically, insider Irene Becklund sold 5,071 shares of Hims & Hers Health stock in a transaction dated Thursday, May 22nd. The stock was sold at an average price of $53.51, for a total value of $271,349.21. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on HIMS shares. Wall Street Zen upgraded Hims & Hers Health from a "hold" rating to a "buy" rating in a research note on Thursday, May 22nd. Bank of America lifted their price target on Hims & Hers Health from $22.00 to $26.00 and gave the company an "underperform" rating in a research note on Tuesday, April 29th. Needham & Company LLC restated a "buy" rating and issued a $61.00 price target on shares of Hims & Hers Health in a research note on Tuesday, May 6th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Hims & Hers Health in a research note on Wednesday, May 7th. Finally, TD Cowen lowered Hims & Hers Health from a "buy" rating to a "hold" rating and cut their price objective for the stock from $44.00 to $30.00 in a research note on Tuesday, April 29th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Hims & Hers Health has an average rating of "Hold" and an average target price of $37.67.

Hims & Hers Health Price Performance

The stock has a 50-day moving average price of $39.15 and a 200 day moving average price of $35.63. The firm has a market cap of $12.11 billion, a price-to-earnings ratio of 122.43 and a beta of 1.84.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.12 by $0.08. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. The business had revenue of $586.01 million for the quarter, compared to analysts' expectations of $535.21 million. During the same quarter in the previous year, the firm earned $0.05 earnings per share. The business's revenue was up 110.7% compared to the same quarter last year. As a group, equities research analysts predict that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

Hedge Funds Weigh In On Hims & Hers Health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Strs Ohio acquired a new position in shares of Hims & Hers Health during the first quarter worth about $1,469,000. Kilter Group LLC boosted its stake in shares of Hims & Hers Health by 1.0% during the 1st quarter. Kilter Group LLC now owns 43,989 shares of the company's stock worth $1,300,000 after acquiring an additional 450 shares in the last quarter. Geneos Wealth Management Inc. purchased a new stake in shares of Hims & Hers Health during the 1st quarter worth approximately $30,000. Intech Investment Management LLC boosted its stake in shares of Hims & Hers Health by 74.5% during the 1st quarter. Intech Investment Management LLC now owns 143,287 shares of the company's stock worth $4,234,000 after acquiring an additional 61,195 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Hims & Hers Health by 23.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 418,699 shares of the company's stock worth $12,373,000 after acquiring an additional 78,543 shares in the last quarter. Hedge funds and other institutional investors own 63.52% of the company's stock.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.